Literature DB >> 16365400

Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors.

Vikas Sharma1, Mario Delgado, Doina Ganea.   

Abstract

Following antigenic stimulation and differentiation, Th1 and Th2 effector cells contribute differently to cellular and humoral immunity. Vasoactive intestinal peptide (VIP) induces Th2 responses by promoting Th2 differentiation and survival. In this study, we investigate the mechanisms for the protective effect of VIP against activation-induced cell death (AICD) of Th2 effectors. Surprisingly, microarray and protein data indicate that VIP prevents the up-regulation of granzyme B (GrB) in Th2 but not Th1 effectors. This is the first report of GrB expression in Th cells and of its involvement in activation-induced apoptosis. The enhanced responsiveness of Th2 cells to VIP is probably due to the higher expression of VIP receptors. The effect of VIP on Th2 survival and GrB expression is mediated through the VIP receptors 1 and 2 and cAMP signaling through exchange protein activated by cAMP and, to a lesser degree, protein kinase A. In addition to effects on GrB, VIP also down-regulates Fas ligand (FasL) and perforin (Pfr) expression. The extrinsic Fas/FasL pathway and the intrinsic GrB-dependent pathway act independently in inducing AICD. The mechanisms by which GrB induces cell death in Th1/Th2 effectors include both fratricide and suicide. Fratricide killing, prevalent in wild-type cells, is calcium and Pfr dependent, whereas the cell death of Pfr-deficient Th cells involves Fas and GrB but is calcium independent. This study identifies GrB as a new significant player in Th1/Th2 AICD and characterizes two mechanisms for the protective effect of VIP on Th2 survival, i.e., the down-regulation of GrB and FasL expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365400     DOI: 10.4049/jimmunol.176.1.97

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

Authors:  Mario Delgado; Doina Ganea
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

2.  Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.

Authors:  Sheri Tinnell Dorsam; Emilie Vomhof-Dekrey; Rebecca J Hermann; Jodie S Haring; Travis Van der Steen; Erich Wilkerson; Goran Boskovic; James Denvir; Yulia Dementieva; Donald Primerano; Glenn Paul Dorsam
Journal:  Mol Immunol       Date:  2010-02-01       Impact factor: 4.407

Review 3.  Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.

Authors:  Mario Delgado; Doina Ganea
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

4.  Vasoactive intestinal peptide signaling axis in human leukemia.

Authors:  Glenn Paul Dorsam; Keith Benton; Jarrett Failing; Sandeep Batra
Journal:  World J Biol Chem       Date:  2011-06-26

5.  Foxp3⁺ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis.

Authors:  Lei Tian; John A Altin; Lydia E Makaroff; Dean Franckaert; Matthew C Cook; Christopher C Goodnow; James Dooley; Adrian Liston
Journal:  Blood       Date:  2011-06-28       Impact factor: 22.113

6.  The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress.

Authors:  C H Bird; M E Christensen; M S J Mangan; M D Prakash; K A Sedelies; M J Smyth; I Harper; N J Waterhouse; P I Bird
Journal:  Cell Death Differ       Date:  2014-01-31       Impact factor: 15.828

Review 7.  The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.

Authors:  D Ganea; K M Hooper; W Kong
Journal:  Acta Physiol (Oxf)       Date:  2014-12-11       Impact factor: 6.311

8.  Granzyme B- and Fas ligand-mediated cytotoxic function induced by mitogenic CD28 stimulation of human memory CD4+ T cells.

Authors:  Miguel A Medina; Jacob Couturier; Marsha L Feske; Ashley E Mahne; Mary Turner; Xiaoyong Yu; Claudia A Kozinetz; Aaron F Orozco; Alexander T Hutchison; Tor C Savidge; John R Rodgers; Dorothy E Lewis
Journal:  J Leukoc Biol       Date:  2012-03-13       Impact factor: 4.962

9.  Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect.

Authors:  Wei Du; Hemn Mohammadpour; Rachel E O'Neill; Sandeep Kumar; Chuan Chen; Michelle Qiu; Lin Mei; Jingxin Qiu; Philip L McCarthy; Kelvin P Lee; Xuefang Cao
Journal:  Oncoimmunology       Date:  2017-11-16       Impact factor: 8.110

10.  HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.

Authors:  Jacob Couturier; Alexander T Hutchison; Miguel A Medina; Cosmina Gingaras; Petri Urvil; Xiaoying Yu; Chi Nguyen; Parag Mahale; Lin Lin; Claudia A Kozinetz; Joern E Schmitz; Jason T Kimata; Tor C Savidge; Dorothy E Lewis
Journal:  Virology       Date:  2014-07-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.